Fresenius Medical Care AG & Co. KGaA - Asset Resilience Ratio
Fresenius Medical Care AG & Co. KGaA (FMEA) has an Asset Resilience Ratio of 0.77% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Fresenius Medical Care AG & Co. KGaA debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2025)
This chart shows how Fresenius Medical Care AG & Co. KGaA's Asset Resilience Ratio has changed over time. See Fresenius Medical Care AG & Co. KGaA shareholders equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Fresenius Medical Care AG & Co. KGaA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see FMEA stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €238.77 Million | 0.77% |
| Total Liquid Assets | €238.77 Million | 0.77% |
Asset Resilience Insights
- Limited Liquidity: Fresenius Medical Care AG & Co. KGaA maintains only 0.77% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Fresenius Medical Care AG & Co. KGaA Industry Peers by Asset Resilience Ratio
Compare Fresenius Medical Care AG & Co. KGaA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Chemed Corp
NYSE:CHE |
Medical Care Facilities | 14.55% |
|
Top Choice Medical Investment Co Inc
SHG:600763 |
Medical Care Facilities | 0.02% |
|
Mitra Keluarga Karyasehat Tbk PT
JK:MIKA |
Medical Care Facilities | 29.80% |
|
Oceania Healthcare Ltd
AU:OCA |
Medical Care Facilities | 0.01% |
|
Ramsay Health Care Ltd
AU:RHC |
Medical Care Facilities | 3.49% |
|
Regis Healthcare Ltd
AU:REG |
Medical Care Facilities | 2.29% |
|
Pacific Smiles Group Ltd
AU:PSQ |
Medical Care Facilities | 10.35% |
|
Freedom Care Group Holdings Ltd
AU:FCG |
Medical Care Facilities | 0.39% |
Annual Asset Resilience Ratio for Fresenius Medical Care AG & Co. KGaA (2016–2025)
The table below shows the annual Asset Resilience Ratio data for Fresenius Medical Care AG & Co. KGaA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.77% | €238.77 Million ≈ $279.15 Million |
€31.00 Billion ≈ $36.24 Billion |
-0.11pp |
| 2024-12-31 | 0.88% | €295.63 Million ≈ $345.62 Million |
€33.57 Billion ≈ $39.24 Billion |
+0.48pp |
| 2023-12-31 | 0.40% | €136.29 Million ≈ $159.33 Million |
€33.93 Billion ≈ $39.67 Billion |
-0.07pp |
| 2022-12-31 | 0.48% | €169.98 Million ≈ $198.73 Million |
€35.75 Billion ≈ $41.80 Billion |
+0.08pp |
| 2021-12-31 | 0.40% | €136.36 Million ≈ $159.42 Million |
€34.37 Billion ≈ $40.18 Billion |
-0.11pp |
| 2020-12-31 | 0.51% | €161.69 Million ≈ $189.03 Million |
€31.69 Billion ≈ $37.05 Billion |
+0.11pp |
| 2019-12-31 | 0.40% | €133.32 Million ≈ $155.87 Million |
€32.93 Billion ≈ $38.50 Billion |
+0.03pp |
| 2018-12-31 | 0.38% | €99.59 Million ≈ $116.43 Million |
€26.24 Billion ≈ $30.68 Billion |
+0.37pp |
| 2017-12-31 | 0.01% | €3.48 Million ≈ $4.07 Million |
€24.03 Billion ≈ $28.09 Billion |
-0.97pp |
| 2016-12-31 | 0.98% | €251.32 Million ≈ $293.82 Million |
€25.61 Billion ≈ $29.94 Billion |
-- |
About Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arr… Read more